You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Immunostimulating drugs like thymostimulin (TP1) and levamisole did not improve hyper IgE syndrome (HIES) clinical symptoms. While some lab values changed, TP1 worsened outcomes in some patients, necessitating critical analysis of current HIES therapies.
Area of Science:
Background:
Observation:
Findings:
Implications: